CD16 antigen constitutes the low affinity FC receptor for IgG(FcgRIII) DE 50-65 kDA. It is a membrane glycoprotein anchored via phosphatidyl-inositol or a transmembrane isoform. CD16 is expressed by NK cells, granulocytes and macrophages.
| Inventor | Institute |
|---|---|
| Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot and Federico Garrido Torres-Puchol | Virgen de las Nieves University Hospital, The Andalusian Health Service |
| SKU: | 161692 |
|---|---|
| Product description: | CD16 antigen constitutes the low affinity FC receptor for IgG(FcgRIII) DE 50-65 kDA. It is a membrane glycoprotein anchored via phosphatidyl-inositol or a transmembrane isoform. CD16 is expressed by NK cells, granulocytes and macrophages. |
| Isotype: | IgG1ak |
| Molecular weight: | 50-65 kDa |
| Immunogen: | B-ALL cells |
| Cat. #: | 161692 |
|---|---|
| Tool sub type: | Primary antibody |
| Cancer types: | Blood cancer |
| Research Fields: | Cancer |
| Application: | FACS; IHC; ELISA; WB |
| Target: | CD16 |
| Reactivity: | Human |
| Clone: | GRM1 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Ruiz-Cabello et al. 1987. Nat Immun Cell Growth Regul. 6(2):99-108. PMID: 2439907 |
| Storage buffer: | PBS with 0.02% azide |
|---|---|
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Ruiz-Cabello et al. 1987. Nat Immun Cell Growth Regul. 6(2):99-108. PMID: 2439907 |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.